Press Release Karyopharm Plans to Submit sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis Under Accelerated Approval Pathway 30 July 2026
Press Release Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer 30 July 2026
